| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 20.29B | 19.50B | 13.09B | 14.59B | 15.33B |
| Gross Profit | 5.93B | 6.39B | 6.72B | 6.98B | 8.74B |
| EBITDA | 4.10B | 4.64B | 8.13B | 5.95B | 7.39B |
| Net Income | 938.00M | 808.00M | 3.24B | 2.75B | 10.36B |
Balance Sheet | |||||
| Total Assets | 209.31B | 201.35B | 208.43B | 201.47B | 200.06B |
| Cash, Cash Equivalents and Short-Term Investments | 16.10B | 10.98B | 13.54B | 11.70B | 18.30B |
| Total Debt | 55.82B | 59.62B | 55.22B | 55.84B | 37.85B |
| Total Liabilities | 90.12B | 84.70B | 87.28B | 78.99B | 67.74B |
| Stockholders Equity | 105.27B | 103.31B | 107.26B | 108.79B | 116.83B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -3.94B | -5.34M | -23.36B | 11.23B |
| Operating Cash Flow | 0.00 | 1.17B | 4.98B | 1.33B | 11.93B |
| Investing Cash Flow | 0.00 | -5.40B | -2.45B | -17.14B | 8.30B |
| Financing Cash Flow | 0.00 | 2.09B | -47.18M | 13.55B | -13.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$395.26B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$169.60B | 12.36 | 2.75% | 4.33% | 27.01% | -20.16% | |
66 Neutral | HK$223.77B | 3.64 | 8.80% | 5.18% | 2.11% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$135.83B | 10.85 | 3.54% | 4.54% | -9.39% | -19.08% | |
52 Neutral | HK$33.64B | 22.49 | 0.90% | 6.48% | 2.27% | 16.09% | |
51 Neutral | HK$72.43B | 1,328.75 | 0.03% | 1.76% | -9.23% | ― |